Mutations in MUC16 and TTN were associated with associated with improved overall survival (OS), and the mutation status and number of mutations in MUC16 and TTN were effective predictors of tumor mutational burden (TMB) (Yang et al., 2020). Here, MUC16 is linked to neoplasm.